Revisiting the hemodialysis dose

Seminars in Dialysis

Volumn 19, Issue 2, 2006, Pages 96-101

  Leypoldt, John K ^a,c   Cheung, Alfred K ^b,c  

^a UNIVERSITY OF UTAH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID; UREA;

BIOLOGICAL MODEL; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; SEX DIFFERENCE;

DIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MODELS, BIOLOGICAL; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RENAL DIALYSIS; SEX FACTORS; UREA;

EID: 33645276292     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2006.00132.x     Document Type: Review

References (26)

1. Vanholder R De Smet R Glorieux G Argiles A Baurmeister U Brunet P Clark W Cohen G De Deyn PP Deppisch R Descamps-Latscha B Henle T Jorres A Lemke HD Massy ZA Passlick-Deetjen J Rodriguez M Stegmayr B Stenvinkel P Tetta C Wanner C Zidek W Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63 1934 1943 2003
2. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation. Am J Kidney Dis 30 3 suppl 2 S15 S66 1997
3. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. Am J Kidney Dis 37 1 suppl 1 S7 S64 2001
4. Daugirdas JT Second generation logarithmic estimates of single-pool variable Volume Kt/V: an analysis of error. J Am Soc Nephrol 4 1205 1213 1993
5. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association Section II. Haemodialysis adequacy. Nephrol Dial Transplant 17 suppl 7 16 31 2002
6. Greene T Beck GJ Gassman JJ Gotch FA Kusek JW Levey AS Levin NW Schulman G Eknoyan G Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials 21 502 525 2000
7. Eknoyan G Beck GJ Cheung AK Daugirdas JT Greene T Kusek JW Allon M Bailey J Delmez JA Depner TA Dwyer JT Levey AS Levin NW Milford E Ornt DB Rocco MV Schulman G Schwab SJ Teehan BP Toto R Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 2010 2019 2002
8. Depner T Daugirdas J Greene T Allon M Beck G Chumlea C Delmez J Gotch F Kusek J Levin N Macon E Milford E Owen W Star R Toto R Eknoyan G Dialysis dose and the effect of gender and body size on outcome in the HEMO study. Kidney Int 65 1386 1394 2004
9. Cheung AK Levin NW Greene T Agodoa L Bailey J Beck G Clark W Levey AS Leypoldt JK Ornt DB Rocco MV Schulman G Schwab S Teehan B Eknoyan G Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 14 3251 3263 2003
10. Gotch FA Sargent JA A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28 526 534 1985
11. Sargent JA Gotch FA The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int Suppl 2 35 44 1975
12. Lowrie EG The normalized treatment ratio (Kt/V) is not the best dialysis dose parameter. Blood Purif 18 286 294 2000
13. Chertow GM Owen WF Lazarus JM Lew NL Lowrie EG Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 56 1872 1878 1999
14. Lowrie EG Chertow GM Lew NL Lazarus JM Owen WF The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 56 729 737 1999
15. Lowrie EG Li Z Ofsthun N Lazarus JM Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 62 1891 1897 2002
16. Port FK Ashby VB Dhingra RK Roys EC Wolfe RA Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13 1061 1066 2002
17. Wolfe RA Ashby VB Daugirdas JT Agodoa LY Jones CA Port FK Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35 80 88 2000
18. Singer MA Morton AR Mouse to elephant: biological scaling and Kt/V. Am J Kidney Dis 35 306 309 2000
19. Gotch FA The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 13 suppl 6 10 14 1998
20. Leypoldt JK Kablitz C Gregory MC Senekjian HO Cheung AK Prescribing hemodialysis using a weekly urea mass balance model. Blood Purif 9 271 284 1991
21. Depner T Beck G Daugirdas J Kusek J Eknoyan G Lessons from the Hemodialysis (HEMO) study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis 33 142 149 1999
22. Daugirdas JT Schneditz D Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 41 M719 M724 1995
23. Daugirdas JT Greene T Depner TA Leypoldt J Gotch F Schulman G Star R Factors that affect postdialysis rebound in serum urea concentration, including the rate of dialysis: results from the HEMO study. J Am Soc Nephrol 15 194 203 2004
24. Port FK Wolfe RA Hulbert-Shearon TE McCullough KP Ashby VB Held PJ High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 43 1014 1023 2004
25. Chauveau P Nguyen H Combe C Chene G Azar R Cano N Canaud B Fouque D Laville M Leverve X Roth H Aparicio M Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 45 565 571 2005
26. Leypoldt JK Jaber BL Zimmerman DL Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial 17 142 145 2004